metformin has been researched along with Anemia, Hemolytic, Autoimmune in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Anemia, Hemolytic, Autoimmune: Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jandrić Balen, M | 1 |
| Lukenda, V | 1 |
| Jandrić, I | 1 |
| Raguž, A | 1 |
| Zukanović, S | 1 |
| Miškić, B | 1 |
1 other study available for metformin and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
HbA1C - overall glycemia marker and hemolytic anemia indicator.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; G | 2012 |